TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
- PMID: 35178571
- PMCID: PMC9066518
- DOI: 10.1242/dmm.049323
TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
Abstract
Although amyloid β (Aβ) and tau aggregates define the neuropathology of Alzheimer's disease (AD), TDP-43 has recently emerged as a co-morbid pathology in more than half of patients with AD. Individuals with concomitant Aβ, tau and TDP-43 pathology experience accelerated cognitive decline and worsened brain atrophy, but the molecular mechanisms of TDP-43 neurotoxicity in AD are unknown. Synergistic interactions among Aβ, tau and TDP-43 may be responsible for worsened disease outcomes. To study the biology underlying this process, we have developed new models of protein co-morbidity using the simple animal Caenorhabditis elegans. We demonstrate that TDP-43 specifically enhances tau but not Aβ neurotoxicity, resulting in neuronal dysfunction, pathological tau accumulation and selective neurodegeneration. Furthermore, we find that synergism between tau and TDP-43 is rescued by loss-of-function of the robust tau modifier sut-2. Our results implicate enhanced tau neurotoxicity as the primary driver underlying worsened clinical and neuropathological phenotypes in AD with TDP-43 pathology, and identify cell-type specific sensitivities to co-morbid tau and TDP-43. Determining the relationship between co-morbid TDP-43 and tau is crucial to understand, and ultimately treat, mixed pathology AD.
Keywords: Caenorhabditis elegans; Alzheimer's disease; Amyloid β (Aβ); Proteotoxicity; TDP-43; Tau.
© 2022. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interests The authors declare no competing or financial interests.
Figures








Similar articles
-
Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets.Neurobiol Dis. 2024 Apr;193:106441. doi: 10.1016/j.nbd.2024.106441. Epub 2024 Feb 18. Neurobiol Dis. 2024. PMID: 38378122 Free PMC article.
-
Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.Neuropathol Appl Neurobiol. 2020 Dec;46(7):722-734. doi: 10.1111/nan.12664. Epub 2020 Sep 22. Neuropathol Appl Neurobiol. 2020. PMID: 32896913
-
The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death.Brain Res Bull. 2022 Nov;190:204-217. doi: 10.1016/j.brainresbull.2022.10.006. Epub 2022 Oct 13. Brain Res Bull. 2022. PMID: 36244581 Review.
-
MSUT2 is a determinant of susceptibility to tau neurotoxicity.Hum Mol Genet. 2011 May 15;20(10):1989-99. doi: 10.1093/hmg/ddr079. Epub 2011 Feb 25. Hum Mol Genet. 2011. PMID: 21355046 Free PMC article.
-
Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer's disease.Geroscience. 2021 Aug;43(4):1627-1634. doi: 10.1007/s11357-021-00407-0. Epub 2021 Jun 29. Geroscience. 2021. PMID: 34185246 Free PMC article. Review.
Cited by
-
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia.ASN Neuro. 2023 Jan-Dec;15:17590914231158218. doi: 10.1177/17590914231158218. ASN Neuro. 2023. PMID: 36890725 Free PMC article.
-
TDP-43 pathology is associated with increased tau burdens and seeding.Mol Neurodegener. 2023 Sep 30;18(1):71. doi: 10.1186/s13024-023-00653-0. Mol Neurodegener. 2023. PMID: 37777806 Free PMC article.
-
Decreased Hsp90 activity protects against TDP-43 neurotoxicity in a C. elegans model of amyotrophic lateral sclerosis.PLoS Genet. 2024 Dec 26;20(12):e1011518. doi: 10.1371/journal.pgen.1011518. eCollection 2024 Dec. PLoS Genet. 2024. PMID: 39724103 Free PMC article.
-
sut-2 loss of function mutants protect against tau-driven shortened lifespan and hyperactive pharyngeal pumping in a C. elegans model of tau toxicity.MicroPubl Biol. 2023 Aug 3;2023:10.17912/micropub.biology.000844. doi: 10.17912/micropub.biology.000844. eCollection 2023. MicroPubl Biol. 2023. PMID: 37602280 Free PMC article.
-
Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury.Mol Psychiatry. 2023 Jun;28(6):2433-2444. doi: 10.1038/s41380-023-02101-3. Epub 2023 May 17. Mol Psychiatry. 2023. PMID: 37198260 Free PMC article.
References
-
- Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y.et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611. 10.1016/j.bbrc.2006.10.093 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical